Related Experiment Video
Updated: Aug 4, 2026

09:03
Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
Published on: November 23, 2014
Angiogenesis: new insights and therapeutic potential
1Department of Anatomy and Cell Biology, University of Iowa, Iowa City 52242, USA. robert-tomanek@uiowa.edu
The Anatomical Record
|June 27, 2000
Summary
Angiogenesis, the formation of new blood vessels, is vital for growth and disease. Therapies aim to inhibit excessive vascular growth in tumors or stimulate it in ischemic conditions.
Area of Science:
- Vascular biology and medicine
- Cellular and molecular biology
- Pathophysiology
Background:
- Angiogenesis is crucial for normal development and pathological conditions like cancer and ischemic diseases.
- Complex processes involving cell interactions, signaling pathways, and the microenvironment regulate angiogenesis.
- Recent advancements in understanding angiogenic factors, genes, and extracellular matrix components have accelerated progress.
Purpose of the Study:
- To review the current understanding of angiogenesis.
- To highlight the roles of various factors in angiogenic processes.
- To discuss therapeutic strategies targeting angiogenesis.
Main Methods:
- Literature review of scientific publications on angiogenesis.
- Analysis of data from in vitro and in vivo studies.
- Examination of clinical trial rationales.
Main Results:
- Knowledge of angiogenesis has grown exponentially, driven by advances in growth factor and cytokine research.
- Extracellular matrix, adhesion molecules, and metabolic/mechanical factors significantly influence angiogenesis.
- Therapeutic strategies are being developed to inhibit aberrant angiogenesis (e.g., in tumors) or stimulate it (e.g., in ischemia).
Conclusions:
- Angiogenesis is a complex, multifactorial process critical in both health and disease.
- Therapeutic interventions targeting angiogenesis hold significant potential for treating various pathological conditions.
- Further research continues to refine our understanding and application of angiogenic therapies.
Related Concept Videos
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Non-Canonical Wnt Signaling Pathways
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...

